// App-Quantinova.ai

3577 : A Comparison Of Hemostatic and Inflammatory Markers In Overt and Non-Overt DIC

Researchers

Presenter

  • Debra Hoppensteadt

Principal Investigators

  • Kazuhisa Tsuruta

  • Joe Hirman

  • Inder Kaul

  • Yutaka Osawa

  • Jawed Fareed

Medical Centers

  • Loyola University Medical Center, Maywood, IL

Locations

  • United States

Companies

  • Asahi Kasei Medical

  • Pacific Northwest St

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Tuberculosis

  • Venous thrombosis

  • Sepsis

Biomarkers

  • Myeloperoxidase

  • Calcitonin

  • Plasminogen activator ihnibitor-1

  • Complement Component 5a

  • Interleukin 10

  • Interleukin 6

Drug/Treatment

  • Thrombomodulin alfa

  • Interleukin-10

  • Interleukin

  • Hemostatic Solution

  • Protein C

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved